Purpose
|
A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE, HYPERTENSION, PHEOCHROMOCYTOMA, RAYNAUD DISEASE, PROSTATIC HYPERTROPHY, and URINARY RETENTION.
|
Characteristics
|
Tradename: MINIPRESS Source of Compound: synthetic, CP-12299-1 Target: Potassium channel inhibitor,ABC inhibitor,Adrenergic Receptor antagonist ,MRP inhibitor Receptor: Potassium Channel ,ABCG,Adrenergic receptor ,MRP1 Status: USP, INN, BAN, JAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C19H22ClN5O4
|
Solubility
|
DMSO 1 mg/mL, Water <1 mg="" ml="" <="" td="">
1> |